Monday, March 14, 2016

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

www.advfn.com/news_Prospectus-Filed-Pursuant-to-Rule-424b5...
ADVFN
11 hours ago - We plan to expand our Imprimis Cares program by introducing additional customizable compounded drug formulations for patient populations that may not have

No comments: